Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasiaTiewen Li(Shanghai Jiao Tong University), Yuan Ruan(Shanghai Jiao Tong University)Biology DirectAugust 2, 202410.1186/s13062-024-00504-yCited by 11SaveCiteExport RISWatch citationsRelated PapersDeregulation of ATG9A by impaired AR signaling induces autophagy in prostate stromal fibroblasts and promotes BPH progression|Cell Death and Disease|2018|24